SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RXSD Rexall Sundown

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dorine Essey who wrote (164)11/5/1998 5:09:00 PM
From: Anthony Wong   of 327
 
Bloomberg: Sundown Shares Fall on Earnings Outlook, Slowing Sales

Bloomberg News
November 5, 1998, 2:08 p.m. ET

Rexall Sundown Shares Fall on Earnings Outlook, Slowing Sales

Boca Raton, Florida, Nov. 5 (Bloomberg) -- Rexall Sundown
Inc. shares fell as much as 24 percent after an analyst cut his
1999 earnings estimates for the maker of vitamin and nutritional
supplements on concern that its sales are falling faster than its
weakening industry.

Shares of the maker of nutritional supplements fell 4 3/4 to
17 1/4 in midafternoon trading of 9.7 million shares, more than
eight times the three-month daily average. Earlier, the stock
touched 16 3/4.

Rexall, which had 1997 sales of $263.4 million, fell after
analyst John Mahoney at Raymond James & Associates Inc. said
latest retail data indicate the industry showed a 4 percent
decline in sales of supplements for the most recent period, while
Rexall's business fell 6 percent. It's the first time the Boca
Raton, Florida-based company has performed worse than the
industry on a sequential basis, the analyst said in a report.

Mahoney said the decline in retail sales and tough year-over-
year comparisons coming in the spring led him to lower his 1999
earnings estimates to $1.18 a share from $1.29. He cut his rating
on the stock to ''accumulate'' from ''buy.''

In late September, Rexall, which also develops and
distributes its products, said it would buy back as much as $100
million of its common stock with cash on hand since it has no
long-term debt. The stock repurchase followed a decline in the
stock prices of Rexall and its competitors on concern about
pricing pressure from mass-market retailers.

--Jennifer Farley in the Princeton newsroom (609) 279-4104 /jjs

More News: RXSD
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext